Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ferrannini

Showing results (311-320 of 334) with videos related to

Pageof 34
Sort By:
Diabetes|November 1, 1987
Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetesJ P Felber, E Ferrannini, A Golay, et al.
Diabetologia|July 10, 2004
Non-esterified fatty acids impair insulin-mediated glucose uptake and disposition in the liverP Iozzo, R Lautamaki, F Geisler, et al.
International Journal of Obesity (2005)|July 4, 2007
Pattern of expression of adiponectin receptors in human adipose tissue depots and its relation to the metabolic stateM Nannipieri, A Bonotti, M Anselmino, et al.
Diabetes, Obesity & Metabolism|April 5, 2011
High-density lipoprotein-cholesterol and not HbA1c was directly related to cardiovascular outcome in PROactiveE Ferrannini, D J Betteridge, J A Dormandy, et al.
The Journal of Clinical Investigation|July 1, 1993
Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetesR C Bonadonna, S Del Prato, M P Saccomani, et al.
Diabetes|July 1, 1994
Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose productionG Perriello, P Misericordia, E Volpi, et al.
Diabetes|January 8, 1998
Troglitazone reduces LDL oxidation and lowers plasma E-selectin concentration in NIDDM patientsL Cominacini, U Garbin, A Fratta Pasini, et al.
Diabetes, Obesity & Metabolism|May 28, 2011
Metabolic effects of muraglitazar in type 2 diabetic subjectsM Fernandez, A Gastaldelli, C Triplitt, et al.
Diabetologia|August 1, 1988
Oxidative and non-oxidative glucose metabolism in non-obese type 2 (non-insulin-dependent) diabetic patientsA Golay, R A DeFronzo, E Ferrannini, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 6, 2014
HDL lipid composition is profoundly altered in patients with type 2 diabetes and atherosclerotic vascular diseaseC Morgantini, D Meriwether, S Baldi, et al.
Pageof 34

Showing results (311-320 of 334) with videos related to

Sort By:
Pageof 34
Diabetes|November 1, 1987
Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetesJ P Felber, E Ferrannini, A Golay, et al.
Diabetologia|July 10, 2004
Non-esterified fatty acids impair insulin-mediated glucose uptake and disposition in the liverP Iozzo, R Lautamaki, F Geisler, et al.
International Journal of Obesity (2005)|July 4, 2007
Pattern of expression of adiponectin receptors in human adipose tissue depots and its relation to the metabolic stateM Nannipieri, A Bonotti, M Anselmino, et al.
Diabetes, Obesity & Metabolism|April 5, 2011
High-density lipoprotein-cholesterol and not HbA1c was directly related to cardiovascular outcome in PROactiveE Ferrannini, D J Betteridge, J A Dormandy, et al.
The Journal of Clinical Investigation|July 1, 1993
Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetesR C Bonadonna, S Del Prato, M P Saccomani, et al.
Diabetes|July 1, 1994
Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose productionG Perriello, P Misericordia, E Volpi, et al.
Diabetes|January 8, 1998
Troglitazone reduces LDL oxidation and lowers plasma E-selectin concentration in NIDDM patientsL Cominacini, U Garbin, A Fratta Pasini, et al.
Diabetes, Obesity & Metabolism|May 28, 2011
Metabolic effects of muraglitazar in type 2 diabetic subjectsM Fernandez, A Gastaldelli, C Triplitt, et al.
Diabetologia|August 1, 1988
Oxidative and non-oxidative glucose metabolism in non-obese type 2 (non-insulin-dependent) diabetic patientsA Golay, R A DeFronzo, E Ferrannini, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 6, 2014
HDL lipid composition is profoundly altered in patients with type 2 diabetes and atherosclerotic vascular diseaseC Morgantini, D Meriwether, S Baldi, et al.
Pageof 34